Trial · NCT07907601
Registered outcomes46
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
21 to 40 of 46
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Secondary | E. Incidence of exacerbations in the control group | At 6 months | Number of exacerbations |
| Secondary | E. Incidence of exacerbations in the experimental group | At 6 months | Number of exacerbations |
| Secondary | E. Incidence of exacerbations in the control group | At 12 months | Number of exacerbations |
| Secondary | E. Incidence of exacerbations in the experimental group | At 12 months | Number of exacerbations |
| Secondary | F. Incidence of hospitalizations in the control group | At 6 months | Quantitative |
| Secondary | F. Incidence of hospitalizations in the experimental group | At 6 months | Quantitative |
| Secondary | F. Incidence of hospitalizations in the control group | At 12 months | Quantitative |
| Secondary | F. Incidence of hospitalizations in the experimental group | At 12 months | Quantitative |
| Secondary | G. Number of consultations in the control group | At 6 months | Quantitative |
| Secondary | G. Number of consultations in the experimental group | At 6 months | Quantitative |
| Secondary | G. Number of consultations in the control group | At 12 months | Quantitative |
| Secondary | G. Number of consultations in the experimental group | At 12 months | Quantitative |
| Secondary | H. Incidence of cardio-vascular complications in the control group | At 6 months | Quantitative |
| Secondary | H. Incidence of cardio-vascular complications in the experimental group | At 6 months | Quantitative |
| Secondary | H. Incidence of cardio-vascular complications in the control group | At 12 months | Quantitative |
| Secondary | H. Incidence of cardio-vascular complications in the experimental group | At 12 months | Quantitative |
| Secondary | I. Smoking cessation in the control group | At 6 months | Number of patients who were smokers at baseline and have now quit smoking |
| Secondary | I. Smoking cessation in the experimental group | At 6 months | Number of patients who were smokers at baseline and have now quit smoking |
| Secondary | I. Smoking cessation in the control group | At 12 months | Number of patients who were smokers at baseline and have now quit smoking |
| Secondary | I. Smoking cessation in the experimental group | At 12 months | Number of patients who were smokers at baseline and have now quit smoking |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07907601/registered?page=2